Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology-Reference-Cited by-同舟云学术

Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology

Published:2024-05-02 Issue:6 Volume:29 Page:700-705
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Tsuchihashi Kenji,Ito Mamoru,Okumura Yuta,Nio Kenta,Ozaki Yukinori,Nishio Hiroshi,Ichihara Eiki,Miura Yuji,Endo Makoto,Yano Shingo,Maruyama Dai,Yoshinami Tetsuhiro,Susumu Nobuyuki,Takekuma Munetaka,Motohashi Takashi,Ochi Nobuaki,Kubo Toshio,Uchino Keita,Kimura Takahiro,Kamiyama Yutaro,Nakao Shinji,Tamura Shinobu,Nishimoto Hitomi,Kato Yasuhisa,Sato Atsushi,Takano Toshimi,Baba Eishi^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10147-024-02541-z.pdf

Reference12 articles.

1. Weycker D, Li X, Edelsberg J et al (2015) Risk and consequences of chemotherapy-induced febrile neutropenia in patients with metastatic solid tumors. J Oncol Pract 11:47–54

2. Leon Rapoport B, Garcia-Morillo M, Font C et al (2023) A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative. Support Care Cancer 31:628

3. Klastersky J, de Naurois J, Rolston K et al (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27:v111–v118

4. Smith TJ, Bohlke K, Lyman GH et al (2015) Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 33:3199–3212

5. NCCN Clinical Practice Guidelines in Oncology. Hematopoietic growth factors version 3. 2024. Accessed 7 Mar 2024